Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|January 1, 1987
The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegalyR J Comi, P GordenSouthern Medical Journal|November 21, 1998
Long-term medical treatment of ectopic ACTH syndromeR J Comi, P GordenThe Journal of Clinical Investigation|February 1, 1987
Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II diabetesR J Comi, G Grunberger, P GordenBiochemical and Biophysical Research Communications|April 14, 1989
Evidence for exogenous substrate phosphorylation and dimer formation by the activated 190 kDa insulin proreceptor in vitroR F Arakaki, R J Comi, P GordenThe Journal of Clinical Endocrinology and Metabolism|December 1, 1984
Tyrosine kinase activity of the insulin receptor of patients with type A extreme insulin resistance: studies with circulating mononuclear cells and cultured lymphocytesG Grunberger, R J Comi, S I Taylor, et al.Annals of Internal Medicine|January 1, 1989
NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gutP Gorden, R J Comi, P N Maton, et al.The New England Journal of Medicine|July 2, 1987
Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogueR J Comi, N Gesundheit, L Murray, et al.Clinical Endocrinology|March 1, 1992
A prospective examination of octreotide-induced gall-bladder changes in acromegalyR C Eastman, R F Arakaki, T Shawker, et al.The Journal of Laboratory and Clinical Medicine|July 1, 1988
Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patientG Grunberger, R J Comi, J L Carpentier, et al.Pageof 19